{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T11:29:55Z","timestamp":1773142195729,"version":"3.50.1"},"reference-count":7,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.clon.2003.11.015","type":"journal-article","created":{"date-parts":[[2004,1,22]],"date-time":"2004-01-22T05:19:43Z","timestamp":1074748783000},"page":"204-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Reactivation of Hepatitis C Virus after Chemotherapy for Colon Cancer"],"prefix":"10.1016","volume":"16","author":[{"given":"M.E.","family":"Melisko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Venook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2003.11.015_BIB1","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/(SICI)1097-0142(19980915)83:6<1224::AID-CNCR23>3.0.CO;2-6","article-title":"Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies","volume":"83","author":"Zuckerman","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2003.11.015_BIB2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1034\/j.1600-0609.2001.067001045.x","article-title":"Incidence of hepatitis virus and infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignancies","volume":"67","author":"Kawatani","year":"2001","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clon.2003.11.015_BIB3","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/oxfordjournals.annonc.a059022","article-title":"Hepatitis C virus acute exacerbation during chemotherapy and radiotherapy for oesphageal carcinoma","volume":"5","author":"de Pree","year":"1994","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clon.2003.11.015_BIB4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1081\/CNV-120016411","article-title":"Severe liver dysfunction after raltitrexed administration in an HCV-positive colorectal cancer patient","volume":"21","author":"Santini","year":"2003","journal-title":"Cancer Invest"},{"key":"10.1016\/j.clon.2003.11.015_BIB5","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1067\/msy.2002.127166","article-title":"Neoadjuvant treatment of esophageal cancer: immunosuppression following combined radiochemotherapy","volume":"132","author":"Heidecke","year":"2002","journal-title":"Surgery"},{"key":"10.1016\/j.clon.2003.11.015_BIB6","first-page":"967","article-title":"Effect of irinotecan on the phenotype of peripheral blood leukocyte populations in patients with metastatic colorectal cancer","volume":"49","author":"Melichar","year":"2002","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.clon.2003.11.015_BIB7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0140-6736(96)90212-3","article-title":"Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus","volume":"347","author":"Vento","year":"1996","journal-title":"Lancet"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655503004680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655503004680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:23:11Z","timestamp":1760541791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655503004680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0936655503004680"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2003.11.015","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reactivation of Hepatitis C Virus after Chemotherapy for Colon Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2003.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}